Akèy › Kansè pankreyas › Texas › Irving
Etid klinik pou Kansè pankreyas nan Irving, TX
7 etid pou Kansè pankreyas ap chèche patisipan nan sit nan ak bò kote Irving (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Ap rekriteFaz 1
- NEXT Oncology Dallas, Irving
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Ap rekriteFaz 1/2
- NEXT Oncology Dallas, Irving
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Ap rekriteFaz 1/2
- NEXT Dallas, Irving
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Ap rekriteFaz 1
- NEXT Dallas, Irving
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Ap rekriteFaz 1
- Next Oncology Dallas /ID# 276254, Irving
A 2-part Phase 1/2 Open-label Trial on ODM-212
Ap rekriteFaz 1/2
- NEXT Oncology, Irving
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Ap rekriteFaz 1/2
- NEXT, Dallas, Irving
Etid Kansè pankreyas nan lòt vil
- Houston, TX61 etid
- New York City, NY60 etid
- Boston, MA43 etid
- Nashville, TN39 etid
- Los Angeles, CA35 etid
- St. Louis, MO33 etid
- Arlington, VA33 etid
- Baltimore, MD31 etid
- San Antonio, TX31 etid
- Philadelphia, PA26 etid
- Tampa, FL26 etid
- Durham, NC24 etid
Lòt etid nan Irving
- Kansè Poumon ki pa ti selil22 etid
- Kansè (tout kalite)15 etid
- Kansè kolorektal13 etid
- Kansè Metastatik11 etid
- Kansè nan tete7 etid
- Kansè lestomak7 etid
- Karsinòm selil skuamèz tèt ak kou6 etid
- Kansè poumon selil ti6 etid
- Kansè poumon6 etid
- Kansè ovè5 etid
- Kansè Endomèt4 etid
- Kansè tete negatif triple4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.